Time course of clinical and neuroradiological effects of delayed‐release dimethyl fumarate in multiple sclerosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Time course of clinical and neuroradiological effects of delayed‐release dimethyl fumarate in multiple sclerosis

Published:2015-01-02 Issue:4 Volume:22 Page:664-671
ISSN:1351-5101
Container-title:European Journal of Neurology
language:en
Short-container-title:Eur J Neurol

Author:

Kappos L.¹,Giovannoni G.²,Gold R.³,Phillips J. T.⁴,Arnold D. L.⁵,Hotermans C.⁶,Zhang A.⁶,Viglietta V.⁶,Fox R. J.⁷,

Affiliation:

1. Neurology University Hospital Basel Switzerland

2. Queen Mary University of London London UK

3. St Josef Hospital Ruhr University Bochum Germany

4. Multiple Sclerosis Program Baylor Institute for Immunology Research Dallas TX USA

5. Montreal Neurological Institute Montreal QC Canada

6. Biogen Idec Inc. Cambridge MAUSA

7. Mellen Center for Multiple Sclerosis Treatment and Research Cleveland Clinic Cleveland OH USA

Funder

Biogen Idec

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ene.12624

Reference17 articles.

1. Rationale for early intervention with immunomodulatory treatments

2. Clinical effects of natalizumab on multiple sclerosis appear early in treatment course

3. Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

4. Placebo-Controlled Phase 3 Study of Oral BG-12 or Glatiramer in Multiple Sclerosis

5. Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroprotection induced by dimethyl fumarate;Natural Molecules in Neuroprotection and Neurotoxicity;2024

2. Whole blood miRNAs in relapsing MS patients treated with dimethyl fumarate in the phase 4 TREMEND trial;Journal of Neuroimmunology;2023-08

3. Lessons from immunotherapies in multiple sclerosis;Handbook of Clinical Neurology;2023

4. MicroRNAs as a possible biomarker in the treatment of multiple sclerosis;IBRO Neuroscience Reports;2022-12

5. Gut microbiota composition as a candidate risk factor for dimethyl fumarate-induced lymphopenia in multiple sclerosis;Gut Microbes;2022-11-18

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3